EPFL spin-off “Innovative Medicines for Tuberculosis” (iM4TB) has been awarded nearly USD 750,000 by the Bill & Melinda Gates Foundation to develop a breakthrough drug against tuberculosis.
EPFL spin-off “Innovative Medicines for Tuberculosis” (iM4TB) has been awarded nearly USD 750,000 by the Bill & Melinda Gates Foundation to develop a breakthrough drug against tuberculosis.
Professor Stewart Cole has been formally elected into the National Academy of Pharmacy in France as an Associate Member. Created in 1803, the French National Academy of Pharmacy began life as the “Paris Pharmacy Company”, which was officially recognized as a charity in 1877. The organization grew into the “Academy of Pharmacy” in 1946, and took its final form in 1979.